Insider · CIK 0001055951
ORBIMED ADVISORS LLC
Reports to the SEC for 118 companies · NEW YORK, NY
Transactions
50
Companies
118
Filings
2
CIK
0001055951
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-09-28 | ADRXADARx Pharmaceuticals, Inc.C Conversion | — |
| 2026-09-28 | ADRXADARx Pharmaceuticals, Inc.C Conversion | — |
| 2026-09-28 | ADRXADARx Pharmaceuticals, Inc. · Series A Preferred StockC Conversion | — |
| 2026-09-28 | ADRXADARx Pharmaceuticals, Inc.C Conversion | — |
| 2026-09-28 | ADRXADARx Pharmaceuticals, Inc.C Conversion | — |
| 2026-09-28 | ADRXADARx Pharmaceuticals, Inc. · Series B-1 Preferred StockC Conversion | — |
| 2026-09-28 | ADRXADARx Pharmaceuticals, Inc. · Series B Preferred StockC Conversion | — |
| 2026-09-28 | ADRXADARx Pharmaceuticals, Inc. · Series A Preferred StockC Conversion | — |
| 2026-09-28 | ADRXADARx Pharmaceuticals, Inc.C Conversion | — |
| 2026-09-28 | ADRXADARx Pharmaceuticals, Inc. · Series B Preferred StockC Conversion | — |
| 2026-09-28 | ADRXADARx Pharmaceuticals, Inc.C Conversion | — |
| 2026-09-28 | ADRXADARx Pharmaceuticals, Inc. · Series B-1 Preferred StockC Conversion | — |
| 2026-09-28 | ADRXADARx Pharmaceuticals, Inc. · Series C Preferred StockC Conversion | — |
| 2026-09-28 | ADRXADARx Pharmaceuticals, Inc. · Series C Preferred StockC Conversion | — |
| 2026-09-28 | ADRXADARx Pharmaceuticals, Inc.P Purchase | +$1.05M |
| 2026-09-28 | ADRXADARx Pharmaceuticals, Inc.C Conversion | — |
| 2026-09-28 | ADRXADARx Pharmaceuticals, Inc.P Purchase | +$5.1M |
| 2026-09-28 | ADRXADARx Pharmaceuticals, Inc.C Conversion | — |
| 2026-09-28 | ADRXADARx Pharmaceuticals, Inc.P Purchase | +$10M |
| 2026-09-21 | ETRAElectra Therapeutics, Inc. · Series B Convertible Preferred StockC Conversion | — |
| 2026-09-21 | ETRAElectra Therapeutics, Inc.P Purchase | +$15M |
| 2026-09-21 | ETRAElectra Therapeutics, Inc. · Series C Convertible Preferred StockC Conversion | — |
| 2026-09-21 | ETRAElectra Therapeutics, Inc.C Conversion | — |
| 2026-09-21 | ETRAElectra Therapeutics, Inc.C Conversion | — |
| 2026-09-21 | ETRAElectra Therapeutics, Inc. · Series A Convertible Preferred StockC Conversion | — |
| 2026-09-21 | ETRAElectra Therapeutics, Inc. · Series C Convertible Preferred StockC Conversion | — |
| 2026-09-21 | ETRAElectra Therapeutics, Inc.C Conversion | — |
| 2026-09-21 | ETRAElectra Therapeutics, Inc.P Purchase | +$5M |
| 2026-09-21 | ETRAElectra Therapeutics, Inc.C Conversion | — |
| 2026-08-10 | BLSMBlossomHill Therapeutics, Inc.P Purchase | +$10M |
| 2026-08-10 | BLSMBlossomHill Therapeutics, Inc.C Conversion | — |
| 2026-08-10 | BLSMBlossomHill Therapeutics, Inc.C Conversion | — |
| 2026-08-10 | BLSMBlossomHill Therapeutics, Inc. · Series A Preferred StockC Conversion | — |
| 2026-08-10 | BLSMBlossomHill Therapeutics, Inc. · Series B Preferred StockC Conversion | — |
| 2026-08-07 | BRVEBraveheart Bio, Inc.P Purchase | +$30M |
| 2026-08-07 | BRVEBraveheart Bio, Inc.P Purchase | +$4.92M |
| 2026-08-07 | BRVEBraveheart Bio, Inc.C Conversion | — |
| 2026-08-07 | BRVEBraveheart Bio, Inc. · Series A Preferred StockC Conversion | — |
| 2026-07-27 | SCTXScribe Therapeutics, Inc. · Series B Preferred StockC Conversion | — |
| 2026-07-27 | SCTXScribe Therapeutics, Inc.P Purchase | +$15M |
| 2026-07-27 | SCTXScribe Therapeutics, Inc.C Conversion | — |
| 2026-07-07 | SIONSionna Therapeutics, Inc.S Sale | −$3.85M |
| 2026-06-30 | SIONSionna Therapeutics, Inc.S Sale | −$5.27M |
| 2026-06-22 | ELVNEnliven Therapeutics, Inc.S Sale | −$1.13M |
| 2026-06-22 | ELVNEnliven Therapeutics, Inc.S Sale | −$35.7M |
| 2026-06-22 | ELVNEnliven Therapeutics, Inc.S Sale | −$2.1M |
| 2026-06-22 | ELVNEnliven Therapeutics, Inc.S Sale | −$66.5K |
| 2026-06-15 | ELVNEnliven Therapeutics, Inc.S Sale | −$409K |
| 2026-06-15 | ELVNEnliven Therapeutics, Inc.S Sale | −$12.3M |
| 2026-06-11 | STTKShattuck Labs, Inc. · Pre-Funded Warrants (right to buy)P Purchase | — |
Recent filings
- 4ORBIMED ADVISORS LLC0000947871-26-000910SEC(opens sec.gov)
- 4ORBIMED ADVISORS LLC0000947871-26-000880SEC(opens sec.gov)
Companies
- 89bio, Inc.10% OwnerETNB
- ACCELERON PHARMA INCFormer 10% Owner
- ACCELRYS, INC.Insider
- Acutus Medical, Inc.Director, 10% Owner
- Adaptimmune Therapeutics PLCDirectorADAP
- ADARx Pharmaceuticals, Inc.Director, 10% OwnerADRX
- Adicet Bio, Inc.10% OwnerACET
- ALBIREO PHARMA, INC.10% Owner
- Alector, Inc.10% OwnerALEC
- ALPINE IMMUNE SCIENCES, INC.Director
- AMARIN CORP PLC\UKDirectorAMRN
- AMBIT BIOSCIENCES CORP10% Owner
- Anthera Pharmaceuticals IncDirector
- Arcutis Biotherapeutics, Inc.10% OwnerARQT
- ARMO BioSciences, Inc.Director, 10% Owner
- ArriVent BioPharma, Inc.Director, 10% OwnerAVBP
- ARS Pharmaceuticals, Inc.DirectorSPRY
- ARVINAS, INC.10% OwnerARVN
- ARYx Therapeutics, Inc.10% Owner
- Assertio Therapeutics, IncInsider
- ATHERSYS, INC / NEW10% Owner
- Audentes Therapeutics, Inc.10% Owner
- AVANIR PHARMACEUTICALS, INC.Director
- AVEDRO INC10% Owner
- BlossomHill Therapeutics, Inc.DirectorBLSM
- Braveheart Bio, Inc.Director, 10% OwnerBRVE
- CalciMedica, Inc.10% OwnerCALC
- Cartesian Therapeutics, Inc.Director, 10% OwnerRNAC
- ChemoCentryx, Inc.10% Owner
- Compass Therapeutics, Inc.Director, 10% OwnerCMPX
- COMPLETE GENOMICS INC10% Owner
- CONSTELLATION PHARMACEUTICALS INC10% Owner
- Corvus Pharmaceuticals, Inc.Director, 10% OwnerCRVS
- Crinetics Pharmaceuticals, Inc.10% OwnerCRNX
- CRYOCOR INC10% Owner
- CTI BIOPHARMA CORP10% Owner
- Damora Therapeutics, Inc.10% OwnerDMRA
- Decibel Therapeutics, Inc.Director, 10% Owner
- Dimension Therapeutics, Inc.Director, 10% Owner
- Disc Medicine, Inc.DirectorIRON
- Edgewise Therapeutics, Inc.Director, 10% OwnerEWTX
- Electra Therapeutics, Inc.Director, 10% OwnerETRA
- ENCHIRA BIOTECHNOLOGY CORP10% Owner
- Enliven Therapeutics, Inc.10% OwnerELVN
- Euthymics Bioscience, Inc.10% Owner
- Fusion Pharmaceuticals Inc.Director
- GIVEN IMAGING LTDDirector, 10% Owner
- GLAUKOS CorpDirectorGKOS
- Guardant Health, Inc.10% OwnerGH
- ImageneBio, Inc.DirectorIMA
- Inspire Medical Systems, Inc.DirectorINSP
- Intellia Therapeutics, Inc.DirectorNTLA
- INTERCEPT PHARMACEUTICALS, INC.Director
- Janux Therapeutics, Inc.DirectorJANX
- KALA BIO, Inc.10% OwnerKALA
- Keros Therapeutics, Inc.DirectorKROS
- Kinnate Biopharma Inc.Director, 10% Owner
- Kun Run Biotechnology, Inc.10% Owner
- LIFECELL CORPDirector
- LogicBio Therapeutics, Inc.Director, 10% Owner
- Lomond Therapeutics Holdings, Inc.Director
- Loxo Oncology, Inc.Director
- MBX Biosciences, Inc.Director, 10% OwnerMBX
- MEMORY PHARMACEUTICALS CORPDirector
- Mirati Therapeutics, Inc.10% Owner
- Nabriva Therapeutics plcDirector, 10% Owner
- NeuroPace Inc10% OwnerNPCE
- NextCure, Inc.Director, 10% OwnerNXTC
- NxStage Medical, Inc.Director
- ORCHID CELLMARK INCInsider
- Oric Pharmaceuticals, Inc.DirectorORIC
- ORPHAN MEDICAL INC10% Owner
- ORTHOVITA INC10% Owner
- OTONOMY, INC.Director
- Pacira BioSciences, Inc.10% OwnerPCRX
- PALVELLA THERAPEUTICS, INC.10% Owner, See RemarksPVLA
- Pandion Therapeutics, Inc.10% Owner
- Passage BIO, Inc.10% OwnerPASG
- PMV Pharmaceuticals, Inc.10% OwnerPMVP
- Prelude Therapeutics IncDirector, 10% OwnerPRLD
- Prevail Therapeutics Inc.Director, 10% Owner
- Principia Biopharma Inc.10% Owner
- PROJECT SAGE OLDCO, INC.10% Owner
- Q32 Bio Inc.Director, 10% OwnerQTTB
- Relypsa Inc10% Owner
- Repare Therapeutics Inc.DirectorRPTX
- RESPONSE BIOMEDICAL CORPDirector, 10% Owner
- RHYTHM PHARMACEUTICALS, INC.10% Owner, See RemarksRYTM
- scPharmaceuticals Inc.10% OwnerSCPH
- Scribe Therapeutics, Inc.DirectorSCTX
- Shattuck Labs, Inc.DirectorSTTK
- SI-BONE, Inc.DirectorSIBN
- Sierra Oncology, Inc.Director, 10% Owner
- Sionna Therapeutics, Inc.DirectorSION
- Sorrento Tech, Inc.10% Owner
- SpringWorks Therapeutics, Inc.10% Owner
- Spyre Therapeutics, Inc.10% OwnerSYRE
- SteadyMed Ltd.10% Owner
- SUPERNUS PHARMACEUTICALS, INC.10% OwnerSUPN
- SYNLOGIC, INC.DirectorSYBX
- Synthorx, Inc.Director, 10% Owner
- TELA Bio, Inc.10% OwnerTELA
- Terns Pharmaceuticals, Inc.Director, 10% OwnerTERN
- Theseus Pharmaceuticals, Inc.Director, 10% Owner
- Third Harmonic Bio, Inc.Director, 10% Owner
- Traws Pharma, Inc.10% OwnerTRAW
- Tricida, Inc.Director, 10% Owner
- Turning Point Therapeutics, Inc.Director
- Turnstone Biologics Corp.Director
- Upstream Bio, Inc.Director, 10% OwnerUPB
- Verona Pharma plcDirectorVRNA
- ViewRay, Inc.10% Owner
- Volcano CorpDirector
- Whitehawk Therapeutics, Inc.10% OwnerWHWK
- WINDTREE THERAPEUTICS INC /DE/InsiderWINT
- X4 Pharmaceuticals, Inc10% OwnerXFOR
- Xtant Medical Holdings, Inc.10% OwnerXTNT
- Yarrow Bioscience, Inc.DirectorYARW
Address
601 LEXINGTON AVENUE 54TH FLOOR
NEW YORK, NY, 10022